Search

everythinglearnresearchcommunity

for

Search:↓

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.

COVID-19 vaccines caused mostly mild side effects in Bangladeshi medical students, with fewer issues after more doses.

COVID-19 vaccines can cause minor skin reactions, including those related to Bullous Pemphigoid, but these usually resolve on their own.

Long COVID affects about 27% of patients, with higher risk for women, lower education, and certain income levels.

COVID-19 and its vaccine can cause skin issues, but most are minor and resolve on their own.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

COVID-19 increased hair loss cases, but vaccination did not.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Covid-19 vaccination during pregnancy is safe for mothers and babies.

Vaccination and timely treatment reduce the risk of long COVID.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

COVID-19 can cause various skin symptoms, with different patterns seen in younger and older patients.

Monitoring for adverse effects in clinical treatments is crucial.

Biological therapy boosts the immune system to effectively fight melanoma.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.